alcohol glutathione-dependent formaldehyde dehydrogenase Figure 4 from Function, expression and polymorphism of human 3/glutathionedependent dehydrogenase Simplified schematic representation of the

McGill and Jaeschke 2014) and to biomarkers that are amenable to measurement within biofluids that are easy to obtain in humans (e.g., blood and urine)

13 In 1993, The Journal of Clinical Apheresis published a paper detailing the use of TPE as either a first- or second-line therapy to be used with other modalities on disorders such as Raynauds disease, systemic lupus erythematosus, coagulation factor inhibitors, familial hypercholesterolemia, acute Guillain-Barr syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, cryoglobulinemia, Goodpastures syndrome, and thrombotic thrombocytopenic purpura

TCGA, TARGET-AML and DepMap matrices were upper-quantile-normalized and log 2 -transformed before FunMap model training

Mol Pharmacol 50: 656-661, 1996